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Purpose: The aim of this study was to evaluate risk factors for the anatomical and functional 
outcomes of macular hole (MH) surgery with special emphasis on the experience of the surgeon.
Methods: A total of 225 surgeries on idiopathic MHs (IMHs) performed by 6 surgeons with 
a mean follow-up period of 20.5 months were reviewed in this retrospective study. Outcome 
parameters focused on IMH closure, complications and visual acuity improvement. The results 
of MH surgeries performed by experienced surgeons were compared to those of surgeons 
in training.
Results: The average MH size was 381 µm (standard deviation [SD]=168). Brilliant blue G 
(BBG) for internal limiting membrane (ILM) staining was used in 109 (48%) eyes and indocya-
nine green (ICG) in 116 (52%) eyes. As endotamponade, 20% SF6 was used in 38 (17%) cases, 
16% C2F6 in 33 (15%) cases and 16% C3F8 in 154 (68%) cases. IMH closure was achieved 
in 194 eyes (86%). Mean preoperative visual acuity was 0.84 logarithm of the minimum angle 
of resolution (log MAR; SD=0.29, range: 0.3–1.5); surgery led to a mean improvement of 0.40 
(SD=0.37) log MAR. Although the MH closure rate was the same using BBG or ICG for ILM 
peeling, visual acuity improvement was better in eyes peeled with BBG compared to eyes 
peeled with ICG (log MAR: BBG: 0.38 [95% CI: 0.32, 0.44] vs ICG: 0.48 [95% CI: 0.42, 0.54], 
P=0.029). Surgeons with previous experience in vitreoretinal surgery of 6 years achieved 
better visual outcomes compared to surgeons with 0–3 years of experience, regardless of the 
MH size, preoperative visual acuity, time to follow-up or dye used for ILM peeling (0–3 years 
[0.27, ∆log MAR] vs 6 years [0.43, ∆log MAR], P=0.009).
Conclusion: Our results indicate that vitrectomy with ILM peeling performed by 
non-experienced surgeons is a safe procedure leading to good anatomical and functional results. 
Very experienced surgeons may achieve even better functional outcomes.
Keywords: idiopathic macular hole, vitrectomy, ILM peeling, intraocular tamponade, 
brilliant peel
Introduction
Idiopathic macular hole (IMH) is a condition that usually affects patients aged 
50 years, resulting in poor central vision. The prevalence is 3/1,000 with a female 
predominance.1,2
Since the first description of vitreoretinal surgery for macular holes (MHs) by Kelly 
and Wendel,3 operation methods for MH surgery continue to undergo refinement. Vitrec-
tomy, internal limiting membrane (ILM) peeling using dyes such as trypan blue (TB), bril-
liant blue G (BBG) and indocyanine green (ICG) and gas endotamponade have become 
the most frequently carried out procedures.4 Surgical intervention may lead to significant 
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vision improvement and favorable anatomical closure rates 
in 90% of the cases.5–13 Shorter duration of symptoms, earlier 
stage of MH, better preoperative visual acuity and younger 
patient age have been reported to be significantly associated 
with better surgical results.14–20 Recent studies also showed the 
influence of the structure of the external limiting membrane 
(ELM) and the photoreceptor ellipsoid zone (EZ) before and 
after MH surgery on the functional outcome.21
However, after surgical intervention, some MHs still 
remain open or even reopen after several years.22–25
MH surgery can be accompanied by a broad spectrum of 
intra- and postoperative complications, including retinal tears 
and detachments, iatrogenic MHs, macular edema, postopera-
tive endophthalmitis and development of progressive cataract, 
compromising the functional outcome of surgery.26–28
Surgical success depends on microsurgical skills such as 
spatial coordination and precision of movement that largely 
depend on the experience of the surgeon.29
The aim of this study was to evaluate the anatomical 
and functional outcomes of MH surgery at a tertiary care 
academic center with special emphasis on the experience 
of the surgeon.
Materials and methods
study design and inclusion and exclusion 
criteria
This study was designed as a retrospective cohort study. 
In total, we evaluated MH surgeries of 6 surgeons with 
variable levels of experience in vitreoretinal surgery. The 
study was conducted according to the tenets of the Declara-
tion of Helsinki. The ethics committee of the University of 
Regensburg did not require an ethics approval and patient’s 
consent to be sought for this study due to its retrospective 
nature, because all data were de-identified. Medical data were 
obtained by retrospective chart review of patients who under-
went surgery for IMH at the Department of Ophthalmology, 
University of Regensburg Medical Centre, Regensburg, 
Germany, between January 2005 and December 2011. A total 
of 225 eyes of 225 patients with previous MH surgery for 
IMH were included. Inclusion criterion was the presentation 
of a full-thickness IMH. Eyes were excluded from the study if 
they had preexisting ocular diseases that could have adversely 
influenced the outcome of the surgery and all eyes with a 
history of ocular trauma. Moreover, all eyes with a history 
of ocular surgery except for cataract surgery were excluded. 
Preoperative chart data obtained included age of the patient, 
gender, preoperative best-corrected visual acuity (BCVA), 
lens status, visibility of an epiretinal membrane in preop-
erative optical coherence tomography (OCT) scans (Stratus 
OCT [Carl Zeiss Meditec, Jena, Germany] or Spectralis OCT 
[Heidelberg Engineering, Heidelberg, Germany]), stage of 
MH according to the classification of Gass30 and diameter 
of the MH at presentation. The maximum MH diameter was 
defined as the diameter of the aperture (6 radial line scans), 
and only the largest measurement was considered.
anatomical and functional outcomes
The focus of the analysis was the rate of MH closure at the 
postoperative visit 6–8 weeks after surgery. MH closure 
was evaluated by OCT scans. MH closure was defined as 
reattachment of the edges of the hole to the retinal pigment 
epithelium or connection from the edge from side to side. 
The EZ was evaluated on postoperative OCT scans. Lens 
status and intraoperative or postoperative complications were 
taken from the patient’s charts and the operative reports. 
Postoperative endophthalmitis, iatrogenic retinal breaks 
and retinal detachment were considered as intraoperative or 
postoperative complications. The BCVA at the last postop-
erative visit was assessed. Median postoperative follow-up 
was 20.5 months (range: 1–80 months).
surgical technique
All eyes underwent 23 G or 20 G 3-port pars plana vitrectomy 
with ILM peeling and gas endotamponade. All surgeries were 
carried out applying an Alcon Accurus Unit (Alcon, Freiburg, 
Germany). The ILM was stained in all eyes with a vital dye. 
For this purpose, ICG with a concentration of 0.05% (ICG-
Pulsion; Pulsion Medical Systems, Feldkirchen, Germany) or 
brilliant peel (brilliant peel; Geuder, Heidelberg, Germany) 
was used. Staining time ranged between 10 seconds and 
20 seconds.
In all phakic eyes, pars plana vitrectomy was combined 
with clear corneal phacoemulsification and implantation of 
an intraocular lens.
All patients were encouraged to maintain a face-down 
position for at least 1 week after surgery.
surgeon characteristics
In total, we included surgical interventions of 6 vitreoretinal 
surgeons. Due to the retrospective character of the study, 
each surgeon (number [n] 1–6) contributed a different 
number of MH surgeries (n1=36 vs n2=67 vs n3=34 vs n4=31 
vs n5=15 vs n6=42). To describe the surgeon’s individual 
level of experience, operative reports of each surgeon were 
evaluated. The number of years of previous experience in 
vitreoretinal surgery of the surgeon was assigned to each 
MH intervention. Finally, we classified subgroups from 
0 to 6 years of previous experience in vitreoretinal surgery: 
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group I (0–3 years of previous experience in vitreoretinal sur-
gery, n=43), group II (4 years of experience, n=41), group III 
(5 years of experience, n=44) and group IV (6 years of 
experience, n=97). We compared very non-experienced sur-
geons (group I) with very experienced surgeons (group IV). 
Groups II and III were created to detect a potential gain of 
experience influencing the results to demonstrate a prospec-
tive learning curve.
statistical analyses
Data were collected in an SPSS spreadsheet and were ana-
lyzed with SPSS statistical software system version 20.0. 
A P-value of ,0.05 was considered statistically significant. 
All visual acuity values were converted to the logarithm 
of the minimum angle of resolution (log MAR) equivalent 
for statistical analysis. Patient characteristics were sum-
marized by means of mean values (standard deviation, SD) 
and ranges (minimum to maximum) for continuous vari-
ables, as well as by frequency counts and percentages 
for categorical data. For a comparison of 2 continuous 
variables, Student’s t-test was used, while comparisons 
between categorical variables were performed by the use 
of the exact unconditional Pearson’s chi-squared statistic 
(z-pooled). For the comparison of changes in log MAR 
between groups, analysis of covariance (ANCOVA) was 
used including group as the main factor and the baseline 
value of log MAR as a covariate to adjust for baseline dif-
ferences. Associations between patient/surgery character-
istics and closure of the MH were described using logistic 
regression analysis. Univariable and multivariable logistic 
regression models were calculated, while the multivariable 
model contained only variables with a P-value of ,0.05 in 
the univariable model.
Results
Patient characteristics
A total of 225 eyes of 225 patients, aged between 48 and 
85 years (mean =70 [SD=7]), were included in this study. 
Of 225 patients, 73 (32%) were males and 181 (80%) eyes 
undergoing surgery were phakic. In 36 eyes (16%), an 
epiretinal membrane was visible on the OCT images before 
surgery. The mean preoperative visual acuity was 0.84 log 
MAR (SD=0.29, range: 0.3–1.5). On average, the size of 
the MHs was 381 µm (SD=168, range: 50–1,185 µm). All 
baseline characteristics are presented in Table 1.
Operation methods, outcome and 
postoperative complications
A 20 G vitrectomy was performed in 177 (79%) eyes and 
23 G vitrectomy in 48 (21%) eyes. Brilliant peel for ILM 
peeling was used in 109 (48%) eyes and ICG in 116 (52%) 
eyes. As intraocular tamponade, 20% SF6 was used in 38 
(17%) eyes, 16% C2F6 in 33 (15%) eyes and 16% C3F8 
in 154 (68%) eyes. Mean operation time was 63 minutes 
(SD=19, range: 24–117 minutes), while non-experienced 
surgeons needed more time than experienced surgeons 
(group I vs group IV: 75.88 minutes [SD=17.68] vs 53.41 
minutes [SD=13.60]; Table 2).
Table 1 Demographic and clinical patient characteristics
Characteristics Years of previous experience in vitreoretinal surgery P-value
All  
(n=225)
0–3 years  
(n=43)
4 years  
(n=41)
5 years  
(n=44)
6 years  
(n=97)
age (years) 70 (sD=7) 70 (sD=7) 70 (sD=5) 70 (sD=7) 69 (sD=7) 0.822a
gender (male), n (%) 73 (32) 10 (23) 12 (29) 16 (36) 35 (36) 0.434C
side, n (%)
left 112 (50) 19 (44) 18 (44) 24 (54.5) 51 (53) 0.613C
right 113 (50) 24 (56) 23 (56) 20 (46.5) 46 (47)
stage of macular hole*, n (%)
ii 117 (52) 23 (54) 21 (51) 17 (39) 56 (58) 0.292C
iii 72 (32) 13 (30) 15 (37) 15 (34) 29 (30)
iV 36 (16) 7 (16) 5 (12) 12 (27) 12 (12)
Maximum size of hole (µm) 381 (sD=168) 418 (sD=190) 385 (sD=145) 432 (sD=163) 340 (sD=161) 0.007a
lens status, n (%)
Phakic 181 (80) 34 (79) 32 (78) 38 (86) 77 (79) 0.741C
Pseudophakic 44 (20) 9 (21) 9 (22) 6 (14) 20 (21)
epiretinal membrane (OCT), n (%) 36 (16) 3 (7) 9 (22) 8 (18) 16 (17) 0.277C
Visual acuity before surgery (log Mar) 0.84 (sD=0.29) 0.9 (sD=0.28) 0.87 (sD=0.3) 0.9 (sD=0.27) 0.78 (sD=0.3) 0.041a
Notes: Data are presented as n (%) or mean (sD). arepresents anCOVa, Crepresents Pearson’s chi-squared test. *Classification according to Gass.30
Abbreviations: anCOVa, analysis of covariance; log Mar, logarithm of the minimum angle of resolution; Mh, macular hole; OCT, optical coherence tomography; 
sD, standard deviation.
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intraoperative and postoperative complications
Postoperative retinal detachment occurred in 8 eyes (3.6%), 
whereas it occurred more often in groups I (7%) and II (7.3%) 
than in groups III (0%) and IV (2.1%).
In 96 (43%) eyes, kryocoagulation and/or laser photoco-
agulation of retinal breaks or suspected retinal breaks was 
performed during surgery. There were no significant differ-
ences between the more experienced and the less experienced 
groups, but we could see a trend of more use of kryocoagula-
tion and/or lasercoagulation within groups II and III, and less 
retinal treatments in groups I and IV.
Persistent macular edema occurred in 4 of 225 (1.8%) 
eyes. In those cases, cataract surgery was performed 
simultaneously.
Furthermore, no case of endophthalmitis, no case of 
reopening of MHs and no case of iatrogenic MH were 
observed during the follow-up period (Table 2).
anatomical and functional outcomes
In total, MH closure was achieved in 194/225 (86%) eyes after 
primary surgery. Concerning the closure rates, there were no 
significant differences between the groups (Table 3).
Univariable logistic regression analyses were calculated 
with MH closure as the dependent variable and each of the 
risk factors mentioned earlier as independent variables. The 
only variables that yielded significant effects were the size of 
the MH (odds ratio [OR] =2.36 per 100 µm, 95% CI: 1.71, 
3.25, P,0.001) and stage of the MH (P,0.01). Thus, the 
larger the hole, the greater the likelihood that the hole 
remained open. Multivariable logistic regression analysis 
showed that the size of the hole emerged as the only statisti-
cally significant risk factor with an OR of 2.36 per 100 µm 
(95% CI: 1.71, 3.25, P,0.001; Table 3).
The mean BCVA of all patients was 0.84 (SD=0.29, 
range: 0.3–1.5) log MAR before surgery. Median postoperative 
BCVA was obtained at 20.5 months after surgery with a mean 
postoperative visual acuity of 0.40 (SD=0.37) log MAR. Visual 
acuity increased (difference of at least 0.2 units log MAR) in 
143 eyes (64%), remained unchanged in 49 eyes (24%) and 
decreased in 10 eyes (4%). Taking into account the different 
baseline characteristics (preoperative visual acuity, size of the 
MH, follow-up time and dye), visual outcome of the surgeons 
in group I/surgeons with 0–3 years of experience compared to 
group IV/surgeons with 6 years of experience was worse (∆log 
MAR [change of visual acuity after surgery: pre-log MAR–post-
log MAR]: ∆log MAR: group I: vs ∆log MAR: group IV: 0.27 
[0.18, 0.37] vs 0.43 [0.37, 0.49], P=0.009; Table 4).
Table 2 surgery and complications
All (n=225) 0–3 years (n=43) 4 years (n=41) 5 years (n=44) 6 years (n=97)
Follow-up (months) 20.5 (sD=19) 32 (sD=23) 22 (sD=19) 14 (sD=12) 24 (sD=18)
Operation time (minutes) 63 (sD=19) 76 (sD=18) 70 (sD=19) 66 (sD=19) 53 (sD=14)
Dye, n (%)
iCg 116 (52) 43 (100) 15 (37) 9 (20.5) 49 (50.5)
BBg 109 (48) 0 26 (63) 35 (79.5) 48 (49.5)
incision size, n (%)
20 g 177 (79) 43 (100) 31 (76) 24 (54.5) 79 (81)
23 g 48 (21) 0 10 (24) 20 (45.5) 18 (19)
Tamponade, n (%)
sF6 38 (17) 15 (35) 5 (12) 1 (2) 17 (18)
C2F6 33 (15) 8 (19) 4 (10) 8 (18) 13 (13)
C3F8 154 (68) 20 (47) 32 (78) 35 (80) 67 (69)
Postoperative retinal detachment, n (%) 8 (4) 3 (7) 3 (7) 0 2 (2)
Kryocoagulation/laser retinopexy applied, n (%) 96 (43) 15 (35) 22 (54) 24 (55) 35 (36)
Persistent macular edema, n (%) 4 (1.8) 1 (2.3) 1 (2.4) 1 (2.3) 1 (1)
infection, reopening, iatrogenic Mh, n (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Note: Data are presented as n (%) or mean (sD).
Abbreviations: BBg, brilliant blue g; iCg, indocyanine green; Mh, macular hole; sD, standard deviation.
Table 3 Multivariable logistic regression models on Mh closure
n MH 
closure
No MH 
closure
OR (95% CI) P-value
experience
0–3 years 43 36 (84%) 7 (16%) reference category
4 years 41 35 (85%) 6 (15%) 1.23 (0.31, 4.82) 0.768
5 years 44 36 (82%) 8 (18%) 1.02 (0.28, 3.74) 0.976
6 years 97 87 (90%) 10 (10%) 1.00 (0.29, 3.43) 0.993
size Mh 225 351  
(sD=145)
569  
(sD=184)
2.36 (1.71, 3.25)a ,0.001
Notes: Data are presented as n (%) or mean (sD). aPer 100 µm. The odds ratio of 
each experience level refers to the reference category 0–3 years.
Abbreviations: CI, confidence interval; MH, macular hole; OR, odds ratio; SD, 
standard deviation.
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additional results
Dye
ILM peeling with BBG led to a significant better visual 
outcome compared to ILM peeling with ICG (log MAR: 
BBG: 0.38 [95% CI: 0.32, 0.44] vs ICG: 0.48 [95% CI: 
0.42, 0.54], P=0.029).
epiretinal membrane
Eyes with epiretinal membranes seen on the OCT scans 
before surgery had the same functional outcome as eyes 
without epiretinal membranes (∆log MAR: 0.40 [SD=0.37] 
vs 0.40 [SD=0.37], P=0.97).
incision size and retinal detachment
Retinal detachment occurred in 8 of 225 patients. It was only 
observed in the 20 G group (5%, n=8/177 eyes), whereas it never 
occurred after 23 G vitrectomy (0%, n=0/48 eyes, P=0.21).
incision size and intraoperative complications
There was no higher risk (P=0.32) for retinal tears using 20 G 
instruments (45%, 79/177) compared to 23 G vitrectomy 
(35%, 17/48).
integrity of the eZ
Mean OCT follow-up was 6–8 weeks after surgery. Regarding 
61/225 eyes, due to a hardware exchange in the used OCT 
systems, we were unable to evaluate OCT images. In 
92/164 eyes, the EZ was restored, whereas in 72/164 eyes 
no restoration was seen. We could find a positive cor-
relation between restoration of the EZ and the surgeon’s 
experience, but these results were not statistically significant 
(Table 5).
Discussion
This is the first study evaluating the surgeon’s experience 
regarding the success of MH intervention.
Our data show that surgeons in training achieved good 
anatomical and functional results after MH surgery, whereas 
very experienced surgeons gained statistically significant 
better visual outcomes. Several studies have focused on 
the risk factors for non-closure after MH surgery.14–20 
Size of the hole, poor preoperative BCVA and duration of 
symptoms emerged as statistically significant factors for 
non-closure of hole. Moreover, in recent studies, restoration 
of macular structure as the determining factor for postop-
erative functional outcome has been discussed.31 Operation 
methods including the need of ILM peeling with the use 
of different vital dyes (ICG, triamcinolone, TB, BBG) and 
different tamponades (air, gases, oil) and postoperative 
duration of face-down positioning have also been debated 
extensively.32,33 We evaluated the complications and the 
success of MH intervention in relation to the surgeon’s 
level of expertise in vitreoretinal surgery. Previous clinical 
studies have reported more complications occurring in 
cataract surgery during the surgeon’s learning phase.29,34 
In MH surgery, in addition to the difficulties of pars plana 
vitrectomy, peeling of the delicate ILM represents a supple-
mentary challenge for a non-experienced surgeon. Our data 
show that less experienced vitreoretinal surgeons achieved 
an acceptable closure rate of MHs (group I: 84%) as com-
pared to closure rates assessed in previous studies ranging 
from 55% to 100%.5–13
For MH surgery, the prevalence of iatrogenic breaks 
has been reported to be between 0% and 14.6%, with post-
operative retinal detachment occurring in 1.1%–14% of the 
cases.26,35–37 In our study, postoperative retinal detachments 
were seen in 3.6% in total as a result of new or missed 
retinal breaks. No case of endophthalmitis or reopening 
of MH was detected. During the study period, operation 
methods underwent refinement with regard to the use of 
dyes, incision sizes and tamponades. However, there was 
Table 4 Change of visual acuity after surgery (pre-log Mar–post-
log Mar)
n Meana (95% CI) P-value vs reference
experience
0–3 years 37 0.27 (0.18, 0.37) reference
4 years 37 0.38 (0.28, 0.48) 0.144
5 years 39 0.43 (0.31, 0.56) 0.052
6 years 89 0.43 (0.37, 0.49) 0.009
Note: aestimated marginal mean and 95% Ci using an anCOVa adjusted by 
preoperative visual acuity, size of Mh, follow-up time and dye.
Abbreviations: ANCOVA, analysis of covariance; CI, confidence interval; log 
Mar, logarithm of the minimum angle of resolution; Mh, macular hole.
Table 5 Multivariable logistic regression on restoration of macular 
structure (n=164)
n Restoration No 
restoration
OR  
(95% CI)
P-value
experience
0–3 years 24 7 (29%) 17 (71%) reference  
category
4 years 33 21 (64%) 12 (36%) 0.34  
(0.09, 1.28)
0.110
5 years 39 26 (67%) 13 (33%) 0.16  
(0.04, 0.61)
0.007
6 years 68 38 (56%) 30 (44%) 0.70  
(0.21, 2.28)
0.548
size Mh 164 325  
(sD=136)
506 
(sD=164)
2.76  
(1.95, 3.89)a
,0.001
Notes: Data are presented as n (%) or mean (sD). aPer 100 µm. The odds ratio of 
each experience level refers to the reference category 0–3 years.
Abbreviations: CI, confidence interval; OR, odds ratio; SD, standard deviation; 
Mh, macular hole.
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no significant correlation between hole closure and incision 
size and no correlation between the used dyes and gases and 
hole closure.
According to the literature, small-gauge vitreoretinal 
surgery using 23 G or 25 G cannulated systems may be 
advantageous in reducing the incidence of sclerotomy-
associated breaks and postoperative retinal detachment.37 
Our data show that, compared to the 20 G group, with the 
use of 23 G instruments, the risk of intraoperative retinal 
tears could not be reduced. However, postoperative retinal 
detachments were only observed in the 20 G group and never 
in the 23 G group. This result might demonstrate the advan-
tage of microincisional surgery in preventing postoperative 
retinal detachments, but the number of cases was too small 
for statistical testing.
Kryocoagulation and/or lasercoagulation was more 
frequently used in groups II and III than in groups I and IV. 
This result might show that non-experienced surgeons did not 
detect as much suspicious retinal regions as surgeons with a 
wider experience. According to these data, during the learning 
phase, more retinal defects might have been not only created 
but also seen and treated by medium experienced surgeons 
(groups II and III). Very experienced surgeons (group IV) 
probably created less tears and therefore had to treat less.
In our OCT findings, we did not detect any iatrogenic 
MHs. Since only 6 radial line scans with a scan size of 
5,780 µm were performed, small or eccentric iatrogenic MHs 
might have stayed unrevealed.
ICG has been suspected to cause retinal toxicity including 
apoptotic retinal cell death in vitro, optic nerve atrophy and 
persistent visual field defects with clinical studies reporting 
conflicting results.38–41 BBG has been reported to be safe 
with minimal toxicity.42,43 However, our results do show a 
statistically significant trend for a better visual outcome in 
the group of eyes peeled by using BBG.
In total, functional long-term improvement in visual 
acuity (defined as an improvement of 0.2 log MAR) was 
achieved in 64% of the cases, ranging from 0.84 log MAR 
before surgery to 0.45 log MAR postoperatively, which is 
consistent with the findings of other studies.3,6,9
Nevertheless, surgeons with 6 years of previous 
experience in vitreoretinal surgery achieved significantly 
better visual outcomes.
At first sight, this result could also be related to the use 
of ICG. Eyes treated with ICG instead of BBG for ILM 
peeling had worse postoperative visual outcome. In group I 
(0–3 years of experience in vitreoretinal surgery), in all 
cases, ICG was used for ILM peeling, in group IV (the group 
with 6 years of experience) only 49 of 97 (50.5%) eyes 
were peeled with ICG and another 48 of 97 (49.5%) eyes 
were peeled with the help of BBG. Nevertheless, multivariate 
analyses including used dye, MH size, preoperative visual 
acuity and postoperative follow-up showed a statistically 
better visual outcome in group IV, indicating that differ-
ences between the groups concerning visual outcome were 
not depending only on the use of ICG.
Successful MH closure is not always associated with good 
visual rehabilitation. Several studies indicate that restora-
tion of the outer retina plays a key role in good functional 
outcome. The reconstruction of the outer retina seems to be 
the better prognostic factor for a good postoperative visual 
improvement.21,31,44
Our results hint at a trend that restoration of the EZ is 
more frequently achieved according to the surgeon’s expe-
rience, but the differences between the groups were not 
statistically significant.
Conclusion
Our data demonstrate that the only significant risk factor for 
non-closure was the size of the hole. Multivariate statistical 
analysis represented that all other risk factors had no influ-
ence on the anatomical outcome, whereas visual outcome 
after MH surgery correlated with the experience of the 
surgeon. It is possible that, during the surgeon’s learning 
phase, the restoration and structure of the outer retina and 
the functional outcome have been negatively influenced by 
micro-traumata during the ILM peeling or by longer lasting 
exposure of the macular region to vital dyes.
Due to its retrospective design, this study has its limi-
tations. The structure of the outer retina could not be suf-
ficiently examined because of the short and also varying 
OCT follow-up periods. Visual field and near visual acuity 
testing would have been desirable but were not routinely 
performed in this investigation. Moreover, the individual 
experience of each surgeon and also the operation methods 
varied among the groups what is likely to have influenced 
the functional outcome.
However, our results show that surgeons performed well 
in MH surgery because of previous acquired surgical skills 
documented in a good closure rate and acceptable visual out-
come. An additional study would be desirable to examine the 
visual field function and macular morphology in detail in eyes 
operated on MHs during the surgeon’s learning phase.
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